VA Asthma Claims: DC 6602 Ratings and Service Connection

What the VA Counts as Bronchial Asthma

For VA purposes, bronchial asthma is rated under 38 CFR 4.97, diagnostic code 6602. Asthma is a chronic disease of the airways that causes them to narrow, swell, and produce extra mucus, leading to wheezing, shortness of breath, chest tightness, and coughing. The condition is variable: it can be quiet for stretches and then flare into an attack triggered by allergens, exercise, cold air, infection, or irritants such as smoke or dust.

How the Rating Mechanics Work

DC 6602 is unusual because each rating level lists several independent ways to qualify, joined by the word "or." You do not have to meet every criterion in a level. Meeting any single one of them is enough to reach that percentage. The VA assigns the highest level your evidence supports.

The dual pulmonary-function thresholds

Two breathing numbers can each independently set the rating: the FEV-1 (percent predicted) and the FEV-1/FVC ratio (a percentage). The thresholds run in parallel. For example, an FEV-1 of 56 to 70 percent predicted supports 30 percent, and so does an FEV-1/FVC ratio of 56 to 70 percent, separately. Because the two can disagree, the rule below for which test the rater uses matters.

The parallel medication criteria (often the higher path)

Alongside the breathing numbers, the type of treatment you require can drive the rating on its own, and frequently lands higher than the numbers suggest. The schedule reads:

• 30 percent: daily inhalational or oral bronchodilator therapy, or inhalational anti-inflammatory medication (this includes daily inhaled corticosteroids).
• 60 percent: at least monthly visits to a physician for required care of exacerbations, or intermittent (at least three per year) courses of systemic (oral or parenteral) corticosteroids.
• 100 percent: daily use of systemic (oral or parenteral) high-dose corticosteroids or immunosuppressive medications, or more than one attack per week with episodes of respiratory failure.

The post-bronchodilator PFT rule

Post-bronchodilator studies are generally required when pulmonary function tests are done for rating purposes (an exception applies when pre-bronchodilator results are normal, or when the examiner explains why a post-bronchodilator test should not be done). (see 38 CFR 4.96(d)) When evaluating based on PFTs, the rater uses the post-bronchodilator results, unless those results were poorer than the pre-bronchodilator results, in which case the pre-bronchodilator values are used. If different tests disagree and would yield different ratings, the examiner identifies the result that most accurately reflects the level of disability.

DC 6602 Rating Levels: Bronchial Asthma

The full schedule entry is "6602 Asthma, bronchial" under 38 CFR 4.97. The ladder runs 10, 30, 60, and 100 percent. The criteria below are reproduced verbatim from the current regulation. Remember that each level is satisfied by meeting any one of its listed criteria.

Because each level can be reached by a single qualifying criterion, the medication and treatment-frequency paths are worth checking against your records every time. A veteran whose FEV-1 sits in the 30 percent range on paper can still meet the 60 percent level if a physician treats monthly exacerbations or prescribes three or more courses of systemic steroids a year.

How Bronchial Asthma Gets Service Connected

Direct service connection

Direct service connection requires a current asthma diagnosis, an in-service event, exposure, or onset, and a medical nexus linking the two. The published BVA decisions show that the missing link is overwhelmingly the nexus: of 2,644 classified service-connection denials for asthma, 1,706 were dispositively for lack of a nexus, far ahead of 502 for no current diagnosis and 436 for no in-service event (published BVA decisions, counts of denied service-connection appeals classified by the single missing element). A private medical opinion moved outcomes sharply: approximately 80.3% of asthma appeals were granted when a private nexus opinion was in the file, versus 42.0% without it (published BVA decisions, n = 401 with / 1,789 without).

Presumptive service connection: the PACT Act burn pit pathway

This is the standout path for many post-1990 veterans. Under the PACT Act, bronchial asthma diagnosed after service is a presumptive condition for veterans with qualifying airborne-hazard or burn pit exposure. For a presumptive claim, you do not have to prove a nexus. Qualifying service does the linking work. VA.gov lists asthma among the burn pit and other airborne-hazards presumptive conditions, alongside chronic bronchitis, COPD, chronic rhinitis, chronic sinusitis, constrictive or obliterative bronchiolitis, emphysema, granulomatous disease, interstitial lung disease, pleuritis, pulmonary fibrosis, and sarcoidosis.

Qualifying service generally means the Gulf War theater (on or after August 2, 1990, including Iraq, Kuwait, Saudi Arabia, Bahrain, Oman, Qatar, the United Arab Emirates, Somalia, and the airspace above) or post-9/11 service (on or after September 11, 2001, including Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Syria, Uzbekistan, Yemen, and the airspace above). See the burn pit presumptive walkthrough and the VA.gov PACT Act page.

Secondary to service-connected rhinitis or sinusitis (the "united airway" theory)

This is the strongest secondary pathway in the BVA data. Under the "united airway" concept, the upper airway (nose and sinuses) and lower airway (bronchi) are treated as one connected system, so chronic rhinitis or sinusitis can cause or aggravate asthma. In published decisions, asthma claimed as secondary to allergic or vasomotor rhinitis (DC 6522) was granted at approximately a 75% rate (35 such appeals, published BVA decisions), the standout secondary theory. Asthma claimed as secondary to sinusitis (DC 6510) was granted at roughly 35% (26 appeals). A secondary claim under 38 CFR 3.310 turns on a medical opinion linking the service-connected upper-airway condition to the asthma. See secondary conditions and nexus letters.

The GERD-asthma association

Gastroesophageal reflux disease and asthma frequently co-occur and can aggravate one another. Refluxed acid can irritate the airway and worsen asthma symptoms. In published BVA decisions, asthma claimed as secondary to GERD (DC 7206) was granted at approximately 44% (25 appeals, published BVA decisions). The pathway runs in both directions in the data, which is covered in the secondary section below. See the GERD claims guide.

Common Secondary Conditions

Asthma sits in the middle of a web of related conditions. It can be the downstream condition another service-connected disability caused, and it can be the upstream cause that supports a further claim. All of the rates below are grant rates from published BVA decisions, paired with the number of appeals.

Conditions asthma can cause or contribute to (asthma as the primary)

Each bar is the share of decided appeals (grants plus denials) that were granted. Remanded appeals are listed separately because they were sent back without a final answer.

Pyramiding and Rating Separately

The VA's pyramiding rule at 38 CFR 4.14 bars paying twice for the same symptoms. For respiratory conditions, 38 CFR 4.96(a) adds a specific limit: ratings under several respiratory diagnostic codes (the list includes DC 6600 through 6817 and 6822 through 6847, among them asthma at 6602) generally cannot be combined with each other. Instead, when more than one of those conditions is present, a single rating is assigned under the diagnostic code that reflects the predominant disability.

In practice this means asthma and a second obstructive lung condition such as chronic bronchitis or emphysema are usually evaluated together under the one code that best captures the overall breathing impairment, rather than stacked as separate percentages. Conditions outside the respiratory schedule, such as a separately diagnosed sleep apnea, GERD, or a mental-health condition, are rated under their own diagnostic codes and combined under 38 CFR 4.25, as long as the same symptoms are not counted twice.

Evidence That Wins These Claims

The published BVA decisions point consistently to one piece of evidence above the rest. In asthma decisions that cited each evidence type, the grant rates were:

• A private nexus letter: the top evidence type, with approximately 59% of asthma decisions citing one granted (701 granted of 1,184 that cited it, published BVA decisions).
• Medical literature: approximately 46% granted when cited.
• Buddy or lay statements: approximately 37% granted when cited.
• A private medical opinion: approximately 37% granted when cited.
• The VA examination: approximately 36% granted when cited.
• Service treatment records: approximately 35% granted when cited.

The nexus advantage is also visible in the head-to-head split: approximately 80.3% of asthma appeals were granted when a private nexus opinion was in the file, versus 42.0% without it (published BVA decisions, n = 401 with / 1,789 without). Beyond the nexus, the records that carry weight for an asthma rating are the objective and treatment documents the schedule keys on:

• Post-bronchodilator pulmonary function tests: a spirometry report that clearly labels pre-bronchodilator and post-bronchodilator FEV-1 and FEV-1/FVC values, so the rater can apply the correct number under 38 CFR 4.96(d).
• The Respiratory Conditions DBQ: the examiner documents FEV-1/FVC, the treatment regimen, attack frequency, and exacerbations on the VA's questionnaire. See the DBQ guide.
• Medication records that name the drug class: records that distinguish an inhaled corticosteroid (30 percent level) from a systemic oral or parenteral steroid (60 to 100 percent levels), and that show how often systemic courses were prescribed.
• A verified history of asthmatic attacks: required by the 6602 Note when no asthma findings are present at the exam.

Common Mistakes

Diagnostic Tests and the DBQ

Because DC 6602 keys on both objective numbers and treatment, the exam and the supporting records center on a short list of items:

• Spirometry / pulmonary function tests: these report FEV-1 (percent predicted) and the FEV-1/FVC ratio, the primary objective criteria in the rating table.
• Post-bronchodilator results: per 38 CFR 4.96(d)(4) and (d)(5), post-bronchodilator values are used for rating unless they were poorer than the pre-bronchodilator values, in which case the pre-bronchodilator values are used.
• The VA Respiratory Conditions DBQ: the examiner records FEV-1/FVC, the treatment regimen, attack frequency, and exacerbations on the Disability Benefits Questionnaire.
• Documentation of the treatment regimen: because medication type independently drives the rating, the records should distinguish inhalational bronchodilator therapy (10 to 30 percent), inhalational anti-inflammatory (30 percent), intermittent systemic corticosteroid courses of three or more per year (60 percent), and daily high-dose systemic corticosteroids or immunosuppressives (100 percent).
• Records of physician visits and exacerbations: at least monthly visits for required care of exacerbations supports 60 percent, and episodes of respiratory failure support 100 percent.
• A verified history of asthmatic attacks: required by the 6602 Note when no asthma findings are present at the time of exam.
• Methacholine or bronchoprovocation challenge testing and chest imaging: these can appear when the diagnosis itself is contested, though they are not rating-table criteria. The VA's evaluation of respiratory conditions, including the testing and the systemic-versus-inhalational distinction, is governed by M21-1, Part V, Subpart iii, Chapter 4, Section A (Respiratory Conditions).

Frequently Asked Questions